Tag: metformin

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer Cancer immunotherapy seeks to up regulate immune activators and down regulate immune suppressing agents to induce the body's own immune system to confront malignancy. Nivolumab, a monoclonal antibody to PD1 (immune checkpoint inhibitor), has been tried in highly immunogenic malignancies such...
1.  The addition of insulin to metformin was associated with an increased risk of all-cause mortality and an increased grouped risk of all-cause mortality and myocardial infarction (MI) or stroke relative to the addition of sulfonylureas.  2.  The addition of insulin versus sulfonylureas to metformin did not differ in terms...